IL-27 (NT) Blocking Peptide

IL-27 (NT) Blocking Peptide

Product No.: I-513

[product_table name="All Top" skus="I-513"]

- -
- -
Target
Interleukin-27
Product Type
Blocking Peptide
Alternate Names
P28, IL30, IL-27, IL-27p28, IL27

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
16 amino acids near the amino terminus of human IL-27.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
16 amino acids near the amino terminus of human IL-27.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
Interleukin-27 (IL-27) is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.1 IL-27 is produced by antigen-presenting cells2 and plays an important function in regulating the activity of B and T lymphocytes.3 IL27 may be a potential therapeutic agent against rheumatoid arthritis (RA) at the onset of the disease.4

References & Citations

1. Yoshimoto T et al. (2004) Cancer Res. 64: 1152 2. De Sauvage FJ et al. (2003) Proceedings of the National Acad of Sci of USA 100: 15047 3. Devergne O et al. (2006) J Immunol. 176: 5890 4. Liew FY et al. (2008) Ann Rheum Dis. 67: 1474
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.